首页 > 最新文献

BJU International最新文献

英文 中文
Cystectomy and lymphadenectomy – we now node how far to go! 膀胱切除术和淋巴结切除术--我们现在知道该走多远了!
IF 4.5 2区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2024-11-21 DOI: 10.1111/bju.16599
Jordan Santucci, Sachin Perera, Niranjan Sathianathen, Marlon Perera, Declan Murphy, Nathan Lawrentschuk
Click on the article title to read more.
点击文章标题阅读更多内容。
{"title":"Cystectomy and lymphadenectomy – we now node how far to go!","authors":"Jordan Santucci, Sachin Perera, Niranjan Sathianathen, Marlon Perera, Declan Murphy, Nathan Lawrentschuk","doi":"10.1111/bju.16599","DOIUrl":"https://doi.org/10.1111/bju.16599","url":null,"abstract":"Click on the article title to read more.","PeriodicalId":8985,"journal":{"name":"BJU International","volume":"28 15 1","pages":""},"PeriodicalIF":4.5,"publicationDate":"2024-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142678605","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk of bleeding after retrograde intrarenal surgery vs miniaturised percutaneous nephrolithotomy for 10-20 mm renal stones: a not so different safety profile. 逆行肾内手术与微型经皮肾镜碎石术治疗 10-20 毫米肾结石后的出血风险:安全性并无太大差异。
IF 3.7 2区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2024-11-19 DOI: 10.1111/bju.16585
Davide Perri, Umberto Besana, Matteo Maltagliati, Andrea Pacchetti, Tommaso Calcagnile, Antonio Luigi Pastore, Javier Romero-Otero, Salvatore Micali, Alexander Govorov, Bashkar Somani, Evangelos Liatsikos, Thomas Knoll, Bernardo Rocco, Giorgio Bozzini

Objective: To assess differences in bleeding risk between retrograde intrarenal surgery (RIRS) and minimally invasive miniaturised percutaneous nephrolithotomy (mini-PCNL) for 10-20 mm renal stones.

Patients and methods: A total of 176 patients with a renal stone between 10 and 20 mm were treated. For all patients the Stone Management According to Size-Hardness (SMASH) score was calculated: Hounsfield units × stone maximum size (cm)/100. Patients with score of <15 underwent RIRS (90 patients, Group A), whereas patients with score ≥15 underwent mini-PCNL (86 patients, Group B). In both groups the Cyber Ho laser was used. A statistical analysis was carried out to assess differences in the risk of bleeding.

Results: Preoperative features were comparable. The mean maximum stone diameter was 17.1 and 16.8 mm in Groups A and B, respectively (P = 0.13). The stone-free rate was comparable (87.8% vs 95.3%, P = 0.07). The overall complication rate was 14.4% and 18.6% in Groups A and B, respectively (P = 0.09). Gross haematuria was observed in five cases (5.5%) after RIRS and seven (8.1%) after mini-PCNL (P = 0.07). The mean haemoglobin drop was 12 and 2 g/L at the first and third postoperative day after RIRS vs 17 and 3 g/L after mini-PCNL (P = 0.06 and P = 0.21, respectively). Blood transfusions and renal embolisation were never necessary.

Conclusion: When managing renal stones between 10 and 20 mm taking into account both size and hardness with the application of the SMASH score, RIRS and mini-PCNL show comparable efficacy. A higher bleeding risk has been expected with percutaneous approaches; however, in our cohort the incidence of clinically significant bleeding was low and comparable between the two groups when adopting mini-PCNL.

目的:评估逆行肾内手术(RIRS)和微创微型经皮肾镜取石术(mini-PCNL)治疗10-20毫米肾结石的出血风险差异:共有176名肾结石在10至20毫米之间的患者接受了治疗。对所有患者都计算了结石大小-硬度管理(SMASH)评分:Hounsfield 单位 × 结石最大尺寸(厘米)/100。结果:术前特征相当。A 组和 B 组的平均最大结石直径分别为 17.1 毫米和 16.8 毫米(P = 0.13)。无结石率相当(87.8% vs 95.3%,P = 0.07)。A 组和 B 组的总并发症发生率分别为 14.4% 和 18.6%(P = 0.09)。RIRS 后有 5 例(5.5%)观察到毛细血尿,迷你 PCNL 后有 7 例(8.1%)观察到毛细血尿(P = 0.07)。RIRS 术后第一天和第三天的平均血红蛋白分别下降了 12 克/升和 2 克/升,而迷你 PCNL 术后则分别下降了 17 克/升和 3 克/升(P = 0.06 和 P = 0.21)。结论:结论:在应用 SMASH 评分法治疗 10 至 20 毫米肾结石时,考虑到结石的大小和硬度,RIRS 和迷你 PCNL 的疗效相当。预计经皮方法的出血风险较高;但在我们的队列中,临床显著出血的发生率较低,采用微型 PCNL 的两组之间的发生率相当。
{"title":"Risk of bleeding after retrograde intrarenal surgery vs miniaturised percutaneous nephrolithotomy for 10-20 mm renal stones: a not so different safety profile.","authors":"Davide Perri, Umberto Besana, Matteo Maltagliati, Andrea Pacchetti, Tommaso Calcagnile, Antonio Luigi Pastore, Javier Romero-Otero, Salvatore Micali, Alexander Govorov, Bashkar Somani, Evangelos Liatsikos, Thomas Knoll, Bernardo Rocco, Giorgio Bozzini","doi":"10.1111/bju.16585","DOIUrl":"10.1111/bju.16585","url":null,"abstract":"<p><strong>Objective: </strong>To assess differences in bleeding risk between retrograde intrarenal surgery (RIRS) and minimally invasive miniaturised percutaneous nephrolithotomy (mini-PCNL) for 10-20 mm renal stones.</p><p><strong>Patients and methods: </strong>A total of 176 patients with a renal stone between 10 and 20 mm were treated. For all patients the Stone Management According to Size-Hardness (SMASH) score was calculated: Hounsfield units × stone maximum size (cm)/100. Patients with score of <15 underwent RIRS (90 patients, Group A), whereas patients with score ≥15 underwent mini-PCNL (86 patients, Group B). In both groups the Cyber Ho laser was used. A statistical analysis was carried out to assess differences in the risk of bleeding.</p><p><strong>Results: </strong>Preoperative features were comparable. The mean maximum stone diameter was 17.1 and 16.8 mm in Groups A and B, respectively (P = 0.13). The stone-free rate was comparable (87.8% vs 95.3%, P = 0.07). The overall complication rate was 14.4% and 18.6% in Groups A and B, respectively (P = 0.09). Gross haematuria was observed in five cases (5.5%) after RIRS and seven (8.1%) after mini-PCNL (P = 0.07). The mean haemoglobin drop was 12 and 2 g/L at the first and third postoperative day after RIRS vs 17 and 3 g/L after mini-PCNL (P = 0.06 and P = 0.21, respectively). Blood transfusions and renal embolisation were never necessary.</p><p><strong>Conclusion: </strong>When managing renal stones between 10 and 20 mm taking into account both size and hardness with the application of the SMASH score, RIRS and mini-PCNL show comparable efficacy. A higher bleeding risk has been expected with percutaneous approaches; however, in our cohort the incidence of clinically significant bleeding was low and comparable between the two groups when adopting mini-PCNL.</p>","PeriodicalId":8985,"journal":{"name":"BJU International","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2024-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142667395","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
December's reviewers of the month 12 月份的月度评论员
IF 3.7 2区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2024-11-18 DOI: 10.1111/bju.16576
{"title":"December's reviewers of the month","authors":"","doi":"10.1111/bju.16576","DOIUrl":"10.1111/bju.16576","url":null,"abstract":"","PeriodicalId":8985,"journal":{"name":"BJU International","volume":"134 6","pages":"855"},"PeriodicalIF":3.7,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142672949","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Focus on advances in the management of bladder and kidney cancer 重点关注膀胱癌和肾癌的治疗进展。
IF 3.7 2区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2024-11-18 DOI: 10.1111/bju.16575
{"title":"Focus on advances in the management of bladder and kidney cancer","authors":"","doi":"10.1111/bju.16575","DOIUrl":"10.1111/bju.16575","url":null,"abstract":"","PeriodicalId":8985,"journal":{"name":"BJU International","volume":"134 6","pages":"856-857"},"PeriodicalIF":3.7,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142667397","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Can artificial intelligence evaluate the quality of YouTube videos on erectile dysfunction? 人工智能能否评估 YouTube 上有关勃起功能障碍视频的质量?
IF 3.7 2区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2024-11-18 DOI: 10.1111/bju.16583
Roei Golan, Aden Swayze, Zachary M Connelly, Justin Loloi, Kevin Campbell, Aaron C Lentz, Kara Watts, Alexander Small, Mustufa Babar, Rutul D Patel, Ranjith Ramasamy, Stacy Loeb
{"title":"Can artificial intelligence evaluate the quality of YouTube videos on erectile dysfunction?","authors":"Roei Golan, Aden Swayze, Zachary M Connelly, Justin Loloi, Kevin Campbell, Aaron C Lentz, Kara Watts, Alexander Small, Mustufa Babar, Rutul D Patel, Ranjith Ramasamy, Stacy Loeb","doi":"10.1111/bju.16583","DOIUrl":"10.1111/bju.16583","url":null,"abstract":"","PeriodicalId":8985,"journal":{"name":"BJU International","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142667391","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
‘Case of the Month’ from the University of Verona, Italy—navigating the medical and surgical challenges of urinary bladder paraganglioma: insights from a clinical case 意大利维罗纳大学的 "本月病例"--应对膀胱副神经节瘤的内外科挑战:临床病例的启示
IF 4.5 2区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2024-11-16 DOI: 10.1111/bju.16596
Lorenzo Pierangelo Treccani, Francesco Artoni, Claudio Brancelli, Alessandro Veccia, Mirko D'Onofrio, Isabella Pichiri, Matteo Brunelli, Riccardo Giuseppe Bertolo, Alessandro Antonelli
{"title":"‘Case of the Month’ from the University of Verona, Italy—navigating the medical and surgical challenges of urinary bladder paraganglioma: insights from a clinical case","authors":"Lorenzo Pierangelo Treccani, Francesco Artoni, Claudio Brancelli, Alessandro Veccia, Mirko D'Onofrio, Isabella Pichiri, Matteo Brunelli, Riccardo Giuseppe Bertolo, Alessandro Antonelli","doi":"10.1111/bju.16596","DOIUrl":"https://doi.org/10.1111/bju.16596","url":null,"abstract":"","PeriodicalId":8985,"journal":{"name":"BJU International","volume":"46 1","pages":""},"PeriodicalIF":4.5,"publicationDate":"2024-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142643157","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fluorescence confocal microscopy for margin assessment in prostatectomy: IP8-FLUORESCE study protocol 荧光共聚焦显微镜用于前列腺切除术的边缘评估:IP8-FLUORESCE 研究方案
IF 4.5 2区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2024-11-16 DOI: 10.1111/bju.16588
Nikhil Mayor, Alexander Light, Anna Silvanto, Emma Cullen, Peng Yun Ng, Almostafa Badreldin, Bijan Khoubehi, Giles Hellawell, Francesca Fiorentino, Martin J. Connor, Taimur T. Shah, Hashim U. Ahmed, Mathias Winkler
Radical prostatectomy (RP) represents the cornerstone of surgical treatment for prostate cancer. Assessing surgical margin status intraoperatively with current techniques remains challenging due to high costs in the context of an already stretched pathology workforce. Fluorescence confocal microscopy (FCM) is a promising technique to detect margins in prostate cancer surgery not bound by such limitations.
根治性前列腺切除术(RP)是前列腺癌外科治疗的基石。由于成本高昂,在病理科人手已经十分紧张的情况下,利用现有技术在术中评估手术切缘状态仍具有挑战性。荧光共聚焦显微镜(FCM)是一种很有前途的技术,它可以不受这些限制地检测前列腺癌手术的边缘。
{"title":"Fluorescence confocal microscopy for margin assessment in prostatectomy: IP8-FLUORESCE study protocol","authors":"Nikhil Mayor, Alexander Light, Anna Silvanto, Emma Cullen, Peng Yun Ng, Almostafa Badreldin, Bijan Khoubehi, Giles Hellawell, Francesca Fiorentino, Martin J. Connor, Taimur T. Shah, Hashim U. Ahmed, Mathias Winkler","doi":"10.1111/bju.16588","DOIUrl":"https://doi.org/10.1111/bju.16588","url":null,"abstract":"Radical prostatectomy (RP) represents the cornerstone of surgical treatment for prostate cancer. Assessing surgical margin status intraoperatively with current techniques remains challenging due to high costs in the context of an already stretched pathology workforce. Fluorescence confocal microscopy (FCM) is a promising technique to detect margins in prostate cancer surgery not bound by such limitations.","PeriodicalId":8985,"journal":{"name":"BJU International","volume":"248 1","pages":""},"PeriodicalIF":4.5,"publicationDate":"2024-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142643231","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oncological microdissection testicular sperm extraction (Onco‐microTESE) outcomes for fertility preservation of patients with testicular cancer with azoospermia or severe oligoasthenoteratozoospermia 肿瘤显微切割睾丸取精术(Onco-microTESE)对无精子症或严重少精子症睾丸癌患者保留生育能力的效果
IF 4.5 2区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2024-11-16 DOI: 10.1111/bju.16553
Jack B. Fanshawe, Thomas Hughes, Karen Briggs, Raveen Sandher, Yacoub Khalaf, Tet Yap, Julia Kopeika, Majid Shabbir
ObjectiveTo determine the success rate of oncological microdissection testicular sperm extraction (onco‐microTESE) in patients with testicular cancer (TC) with azoospermia and severe oligoasthenoteratozoospermia (OAT; <1 million/mL sperm) and to explore any factors that may predict success.Patients and MethodsCase series of outcomes from all consecutive patients (42 testes in 38 patients) that presented or were referred to a single specialist tertiary referral centre for fertility management in the context of TC with severe OAT or azoospermia between August 2015 and August 2022. Biochemical, radiological, and histological parameters were collected for all patients. All patients underwent onco‐microTESE (simultaneous radical inguinal orchidectomy with ex vivo microTESE of the affected testis). Those with unsuccessful surgical sperm retrieval (SSR) from the affected testis underwent contemporaneous contralateral microTESE, if no contraindication was present. The primary outcome was successful SSR from the affected testicle sufficient for assisted reproductive techniques. Secondary outcomes included contralateral microTESE success, the time from referral to procedure, and the total successful fertility preservation rate.ResultsInitial onco‐microTESE was successful in 19 of 31 patients (61%) with azoospermia. Contralateral microTESE was successful in a further two of eight patients with azoospermia with failed onco‐microTESE. Overall, 22/31 patients with azoospermia (71%) had successful fertility preservation in this series. In addition, six of seven patients with severe OAT had further sperm harvested by onco‐microTESE to maximise their fertility preservation. All surgery was performed within median (interquartile range) of 7 (5–13) days from presentation.ConclusionsOnco‐microTESE represents an effective method of fertility preservation for sub‐fertile patients with TC without delaying oncological treatment. Knowledge of the fertility status at first presentation is essential to allow for such additional options for optimal fertility preservation in TC.
目的确定肿瘤显微切割睾丸取精术(onco-microTESE)在无精子症和严重少精子症(OAT; <100万/毫升精子)睾丸癌(TC)患者中的成功率,并探讨可能预测成功率的任何因素。患者与方法2015年8月至2022年8月期间,在TC伴有严重OAT或无精子症的情况下,所有连续就诊或转诊至一家三级专科转诊中心进行生育管理的患者(38名患者的42个睾丸)的病例系列结果。收集了所有患者的生化、放射学和组织学参数。所有患者都接受了onco-microTESE(同时进行腹股沟根治性睾丸切除术和受影响睾丸的体外microTESE)。手术取精(SSR)失败的患者,如果没有禁忌症,则同时接受对侧显微睾丸取精术(microTESE)。主要结果是受影响睾丸的手术取精成功,足以用于辅助生殖技术。次要结果包括对侧显微睾丸切除术的成功率、从转诊到手术的时间以及总的成功生育率。在 8 名无精子症患者中,有 2 名患者的共侧显微精囊切除术失败,另外 2 名患者的共侧显微精囊切除术也获得了成功。总体而言,该系列中 22/31 例无精子症患者(71%)成功保留了生育能力。此外,七名重度OAT患者中有六名通过onco-microTESE进一步收获精子,以最大限度地保留生育能力。所有手术均在患者发病后 7(5-13)天的中位数(四分位数间距)内进行。了解首次就诊时的生育状况对于为 TC 患者提供额外的最佳生育力保留方案至关重要。
{"title":"Oncological microdissection testicular sperm extraction (Onco‐microTESE) outcomes for fertility preservation of patients with testicular cancer with azoospermia or severe oligoasthenoteratozoospermia","authors":"Jack B. Fanshawe, Thomas Hughes, Karen Briggs, Raveen Sandher, Yacoub Khalaf, Tet Yap, Julia Kopeika, Majid Shabbir","doi":"10.1111/bju.16553","DOIUrl":"https://doi.org/10.1111/bju.16553","url":null,"abstract":"ObjectiveTo determine the success rate of oncological microdissection testicular sperm extraction (onco‐microTESE) in patients with testicular cancer (TC) with azoospermia and severe oligoasthenoteratozoospermia (OAT; &lt;1 million/mL sperm) and to explore any factors that may predict success.Patients and MethodsCase series of outcomes from all consecutive patients (42 testes in 38 patients) that presented or were referred to a single specialist tertiary referral centre for fertility management in the context of TC with severe OAT or azoospermia between August 2015 and August 2022. Biochemical, radiological, and histological parameters were collected for all patients. All patients underwent onco‐microTESE (simultaneous radical inguinal orchidectomy with <jats:italic>ex vivo</jats:italic> microTESE of the affected testis). Those with unsuccessful surgical sperm retrieval (SSR) from the affected testis underwent contemporaneous contralateral microTESE, if no contraindication was present. The primary outcome was successful SSR from the affected testicle sufficient for assisted reproductive techniques. Secondary outcomes included contralateral microTESE success, the time from referral to procedure, and the total successful fertility preservation rate.ResultsInitial onco‐microTESE was successful in 19 of 31 patients (61%) with azoospermia. Contralateral microTESE was successful in a further two of eight patients with azoospermia with failed onco‐microTESE. Overall, 22/31 patients with azoospermia (71%) had successful fertility preservation in this series. In addition, six of seven patients with severe OAT had further sperm harvested by onco‐microTESE to maximise their fertility preservation. All surgery was performed within median (interquartile range) of 7 (5–13) days from presentation.ConclusionsOnco‐microTESE represents an effective method of fertility preservation for sub‐fertile patients with TC without delaying oncological treatment. Knowledge of the fertility status at first presentation is essential to allow for such additional options for optimal fertility preservation in TC.","PeriodicalId":8985,"journal":{"name":"BJU International","volume":"32 1","pages":""},"PeriodicalIF":4.5,"publicationDate":"2024-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142643219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to Tang et al. ‘Evaluating the efficacy of physiotherapy in post‐prostatectomy continence and pelvic muscle function’ 对 Tang 等人 "评估物理治疗对前列腺切除术后尿失禁和盆腔肌肉功能的疗效 "的回应
IF 4.5 2区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2024-11-13 DOI: 10.1111/bju.16592
Mifuka Ouchi, Takeya Kitta
{"title":"Response to Tang et al. ‘Evaluating the efficacy of physiotherapy in post‐prostatectomy continence and pelvic muscle function’","authors":"Mifuka Ouchi, Takeya Kitta","doi":"10.1111/bju.16592","DOIUrl":"https://doi.org/10.1111/bju.16592","url":null,"abstract":"","PeriodicalId":8985,"journal":{"name":"BJU International","volume":"107 1","pages":""},"PeriodicalIF":4.5,"publicationDate":"2024-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142601207","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
EndoSheath use in flexible cystoscopy: a prospective evaluation of >1000 cases 在柔性膀胱镜检查中使用内鞘:对超过 1000 个病例的前瞻性评估
IF 4.5 2区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2024-11-13 DOI: 10.1111/bju.16578
Lara Ratcliffe, Brian Birch
ObjectivesTo investigate patient tolerability and safety (using urinary tract infection (UTI) as a proxy measure) following EndoSheath‐assisted flexible cystoscopy (eFC). EndoSheaths are single‐use, disposable sheaths used in FC. They reduce cystoscope turnaround times as complicated, time‐consuming and costly sterilisation is no longer necessary. This reduces patient waiting times as cystoscope idle time, the most common rate limiting step, is reduced.Patients and MethodsAll adult patients undergoing eFC over a 26‐month period at a single institution were evaluated prospectively. Post‐eFC, participants rated discomfort on a visual analogue scale (discomfort 1 = none, 2–4 = mild, 5–7 = moderate, 8–10 = severe). The diagnosis of UTI was broad and based on any one of patient self‐report, positive urine culture or antibiotic prescription within 30 days of eFC. Data were analysed using chi‐squared testing (P < 0.05, two‐tailed).ResultsOf the 1091 eFCs analysed, 33.2% and 48.2% of were ranked as causing no or mild discomfort, respectively, with just 3.1% ranked severe. Discomfort was greater in younger participants but similar between sexes. Overall, post‐eFC UTI incidence was 13.3%, with rates higher in females (18.1%) than males (11.2%). Participants aged ≥65 years reported a higher UTI rate (15.4%) than those aged <65 years (8.8%). No participants developed urosepsis.ConclusionThis large, prospective, unselected, real‐world study reports that eFC is well tolerated. UTI was higher in females than males, and in those aged ≥65 years, in line with other studies using the same broad based diagnostic criteria for UTI. The conclusion is that eFC is both well tolerated and safe.
目的研究患者接受内鞘辅助柔性膀胱镜检查(eFC)后的耐受性和安全性(以尿路感染(UTI)作为替代指标)。EndoSheaths 是用于膀胱镜检查的一次性鞘管。由于不再需要复杂、耗时和昂贵的消毒,它们缩短了膀胱镜的周转时间。患者和方法对一家医疗机构在 26 个月内接受 eFC 的所有成年患者进行了前瞻性评估。eFC 术后,参与者用视觉模拟量表对不适感进行评分(不适感 1 = 无,2-4 = 轻度,5-7 = 中度,8-10 = 重度)。UTI的诊断范围很广,基于患者自我报告、尿培养阳性或eFC后30天内的抗生素处方中的任意一种。结果 在分析的 1091 例 eFC 中,分别有 33.2% 和 48.2% 的 eFC 被评为无不适感或轻度不适感,仅有 3.1% 的 eFC 被评为重度不适感。年轻参与者的不适感较强,但男女之间的不适感相似。总体而言,eFC 后尿毒症发生率为 13.3%,女性(18.1%)高于男性(11.2%)。年龄≥65 岁的参与者尿毒症发病率(15.4%)高于年龄为 65 岁的参与者(8.8%)。结论这项大规模、前瞻性、非选择性的真实世界研究表明,eFC 的耐受性良好。女性尿毒症患者多于男性,年龄≥65 岁的患者也较多,这与其他采用相同的尿毒症广泛诊断标准的研究结果一致。结论是 eFC 具有良好的耐受性和安全性。
{"title":"EndoSheath use in flexible cystoscopy: a prospective evaluation of >1000 cases","authors":"Lara Ratcliffe, Brian Birch","doi":"10.1111/bju.16578","DOIUrl":"https://doi.org/10.1111/bju.16578","url":null,"abstract":"ObjectivesTo investigate patient tolerability and safety (using urinary tract infection (UTI) as a proxy measure) following EndoSheath‐assisted flexible cystoscopy (eFC). EndoSheaths are single‐use, disposable sheaths used in FC. They reduce cystoscope turnaround times as complicated, time‐consuming and costly sterilisation is no longer necessary. This reduces patient waiting times as cystoscope idle time, the most common rate limiting step, is reduced.Patients and MethodsAll adult patients undergoing eFC over a 26‐month period at a single institution were evaluated prospectively. Post‐eFC, participants rated discomfort on a visual analogue scale (discomfort 1 = none, 2–4 = mild, 5–7 = moderate, 8–10 = severe). The diagnosis of UTI was broad and based on any one of patient self‐report, positive urine culture or antibiotic prescription within 30 days of eFC. Data were analysed using chi‐squared testing (<jats:italic>P</jats:italic> &lt; 0.05, two‐tailed).ResultsOf the 1091 eFCs analysed, 33.2% and 48.2% of were ranked as causing no or mild discomfort, respectively, with just 3.1% ranked severe. Discomfort was greater in younger participants but similar between sexes. Overall, post‐eFC UTI incidence was 13.3%, with rates higher in females (18.1%) than males (11.2%). Participants aged ≥65 years reported a higher UTI rate (15.4%) than those aged &lt;65 years (8.8%). No participants developed urosepsis.ConclusionThis large, prospective, unselected, real‐world study reports that eFC is well tolerated. UTI was higher in females than males, and in those aged ≥65 years, in line with other studies using the same broad based diagnostic criteria for UTI. The conclusion is that eFC is both well tolerated and safe.","PeriodicalId":8985,"journal":{"name":"BJU International","volume":"35 1","pages":""},"PeriodicalIF":4.5,"publicationDate":"2024-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142601210","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
BJU International
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1